What top creators are saying about Diametica Therapeutics, Inc.(DMAC)
Biotechnology company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Diametica Therapeutics, Inc. in the last 30 days yet.
Top creators covering Diametica Therapeutics, Inc. (DMAC)
The 1 sources with the most insights about Diametica Therapeutics, Inc. on Kazuha.
Latest insights about Diametica Therapeutics, Inc. (DMAC)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, September 8, 2025
Multiple insiders with a good track record are making unusually large purchases, with a 10% owner increasing his holdings by over 50% ($11 million in six weeks), signaling strong confidence.
Monday, September 8, 2025
Multiple insiders with a good track record are making unusually large purchases, with a 10% owner increasing his holdings by over 50% ($11 million in six weeks), signaling strong confidence.
Discussed alongside Diametica Therapeutics, Inc. (DMAC)
Other assets that creators frequently mention in the same content as Diametica Therapeutics, Inc..
Frequently asked
Which podcasters and creators cover Diametica Therapeutics, Inc. (DMAC) the most?
The most active sources covering Diametica Therapeutics, Inc. (DMAC) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Diametica Therapeutics, Inc. (DMAC) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Diametica Therapeutics, Inc. (DMAC) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Diametica Therapeutics, Inc. (DMAC)?
Creators covering Diametica Therapeutics, Inc. (DMAC) most frequently also discuss ULCC, TPVG, CVNA, LQDA, REZI. See the "Discussed alongside" section above for full asset pages.